CRP and ischemic stroke: Previous studies have shown that the levels of several blood biomarkers (ultrasensitive C-reactive protein, lipoprotein-associated phospholipase A2, and metalloproteinase-9) are elevated to varying degrees during the acute phase of ischemic stroke, but changes in a single marker have limitations for the diagnosis of ischemic stroke [8, 9].